Division of Cardiology, Korea University College of Medicine, Seoul, Korea.
Korean Circ J. 2013 Jul;43(7):474-80. doi: 10.4070/kcj.2013.43.7.474. Epub 2013 Jul 31.
Ventricular fibrillation (VF) can inadvertently occur during electrophysiologic study (EPS) or catheter ablation. We investigated the incidence, cause, and progress of inadvertently developed VF during EPS and catheter ablation.
We reviewed patients who had developed inadvertent VF during EPS or catheter ablation. Patients who developed VF during programmed ventricular stimulation to induce ventricular tachycardia or VF were excluded.
Inadvertent VF developed in 11 patients (46.7±9.3 years old) among 2624 patients (0.42%); during catheter ablation for atrial fibrillation (AF) in nine patients, frequent ventricular premature beats (VPBs) in one, and Wolff-Parkinson-White (WPW) syndrome were observed in one. VF was induced after internal cardioversion in six AF patients due to incorrect R-wave synchronization of a direct current shock. Two AF patients showed spontaneous VF induction during isoproterenol infusion while looking for AF triggering foci. The remaining AF patient developed VF after rapid atrial pacing to induce AF, but the catheter was accidentally moved to the right ventricular (RV) apex. A patient with VPB ablation spontaneously developed VF during isoproterenol infusion. The focus of VPB was in the RV outflow tract and successfully ablated. A patient with WPW syndrome developed VF after rapid RV pacing with a cycle length of 240 ms. Single high energy (biphasic 150-200 J) external defibrillation was successful in all patients, except in two, who spontaneously terminated VF. The procedure was uneventfully completed in all patients. At a mean follow-up period of 17.4±15.5 months, no patient presented with ventricular arrhythmia.
Although rare, inadvertent VF can develop during EPS or catheter ablation. Special caution is required to avoid incidental VF during internal cardioversion, especially under isoproterenol infusion.
心室颤动(VF)可能会在电生理研究(EPS)或导管消融过程中无意中发生。我们研究了 EPS 和导管消融过程中无意中发生的 VF 的发生率、原因和进展。
我们回顾了在 EPS 或导管消融过程中发生无意性 VF 的患者。排除了在程序心室刺激诱导室性心动过速或 VF 期间发生 VF 的患者。
在 2624 例患者(0.42%)中,有 11 例(46.7±9.3 岁)发生了无意性 VF;9 例患者因房颤(AF)进行导管消融,1 例患者频发室性期前收缩(VPB),1 例患者存在 Wolff-Parkinson-White(WPW)综合征。在 6 例 AF 患者中,由于直流电复律时 R 波同步不正确,导致复律后发生了 VF。2 例 AF 患者在异丙肾上腺素输注过程中寻找 AF 触发灶时,自发性发生了 VF 诱导。另 1 例 AF 患者在快速心房起搏诱导 AF 后发生了 VF,但导管意外移至右心室(RV)心尖。1 例 VPB 消融患者在异丙肾上腺素输注过程中自发性发生了 VF。VPB 的起源部位位于 RV 流出道,成功消融。1 例 WPW 综合征患者在 RV 快速起搏时,周长为 240 ms,发生了 VF。除 2 例患者 VF 自发终止外,所有患者均成功接受了单相高能(双相 150-200 J)体外除颤。所有患者的手术均顺利完成。在平均 17.4±15.5 个月的随访期间,无患者出现室性心律失常。
尽管罕见,但 EPS 或导管消融过程中可能会无意中发生 VF。在异丙肾上腺素输注期间尤其需要特别注意避免意外的 VF,例如在进行内部复律时。